Neurocrine Biosciences (NBIX) News Today $133.66 +0.91 (+0.69%) Closing price 07/23/2025 04:00 PM EasternExtended Trading$135.48 +1.82 (+1.36%) As of 08:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NBIX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Y Intercept Hong Kong Ltd Takes $1.46 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)4 hours ago | marketbeat.comNeurocrine Biosciences (NBIX) Expected to Announce Earnings on WednesdayJuly 23 at 9:52 AM | marketbeat.comNeurocrine Biosciences (NASDAQ:NBIX) Coverage Initiated by Analysts at Truist FinancialJuly 23 at 4:11 AM | americanbankingnews.comMorgan Stanley Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150.00July 22 at 12:43 PM | marketbeat.comPier 88 Investment Partners LLC Buys 3,860 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 22 at 11:40 AM | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Purchased by Teachers Retirement System of The State of KentuckyJuly 22 at 8:12 AM | marketbeat.comTruist Securities Initiates Coverage of Neurocrine Biosciences (NBIX) with Buy RecommendationJuly 21 at 2:49 PM | msn.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by GW&K Investment Management LLCJuly 21 at 9:26 AM | marketbeat.comTruist Financial Begins Coverage on Neurocrine Biosciences (NASDAQ:NBIX)July 21 at 8:15 AM | marketbeat.comCwm LLC Sells 11,384 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 21 at 3:55 AM | marketbeat.comJennison Associates LLC Sells 16,228 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 19, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Envestnet Asset Management Inc.July 19, 2025 | marketbeat.comHussman Strategic Advisors Inc. Acquires 16,800 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 18, 2025 | marketbeat.comSegall Bryant & Hamill LLC Boosts Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 18, 2025 | marketbeat.comCerity Partners LLC Trims Stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 18, 2025 | marketbeat.comQ2 EPS Estimate for Neurocrine Biosciences Cut by AnalystJuly 18, 2025 | americanbankingnews.comWedbush Predicts Reduced Earnings for Neurocrine BiosciencesJuly 18, 2025 | americanbankingnews.comWedbush Issues Pessimistic Forecast for NBIX EarningsJuly 17, 2025 | marketbeat.comNew York State Common Retirement Fund Decreases Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 17, 2025 | marketbeat.comM&T Bank Corp Sells 2,740 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 17, 2025 | marketbeat.comWedbush Brokers Decrease Earnings Estimates for NBIXJuly 17, 2025 | americanbankingnews.comWedbush Research Analysts Reduce Earnings Estimates for NBIXJuly 16, 2025 | marketbeat.comWilliam Blair Issues Negative Forecast for NBIX EarningsJuly 16, 2025 | marketbeat.comMutual of America Capital Management LLC Sells 2,165 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 16, 2025 | marketbeat.comNeurocrine Biosciences, Inc.: Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst Studies Showing Improvements in Weight-Related Effects of Glucocorticoid ...July 15, 2025 | finanznachrichten.deNeurocrine Biosciences Leverages PicnicHealth to Reveal Critical Care Gaps for Patients with Rare Genetic ConditionJuly 15, 2025 | finance.yahoo.comNeurocrine Biosciences Leverages PicnicHealth to Reveal Critical Care Gaps for Patients with Rare Genetic ConditionJuly 15, 2025 | prnewswire.comNeurocrine Biosciences Presents New Analysis of CAHtalog® Registry Showing Most Patients with Classic Congenital Adrenal Hyperplasia Experienced High Glucocorticoid Exposure, Suboptimal Disease Control or Both at ENDO 2025July 15, 2025 | prnewswire.comWilliam Blair Issues Pessimistic Estimate for NBIX EarningsJuly 15, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Holdings Raised by Nisa Investment Advisors LLCJuly 15, 2025 | marketbeat.comNeurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalystâ„¢ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society's Annual MeetingJuly 14, 2025 | prnewswire.comNeurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY® (crinecerfont) in Adult Patients, at ENDO 2025July 14, 2025 | prnewswire.comLeerink Partnrs Issues Positive Estimate for NBIX EarningsJuly 14, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Ingrid Delaet Sells 457 SharesJuly 12, 2025 | insidertrades.comLbp Am Sa Has $256,000 Stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 12, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Ingrid Delaet Sells 457 SharesJuly 11, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells $7,803,986.74 in StockJuly 11, 2025 | marketbeat.comNeurocrine Biosciences (NBIX) CSO Onyia sells $7.8m in stockJuly 11, 2025 | investing.comGoldman Sachs Initiates Coverage of Neurocrine Biosciences (NBIX) with Buy RecommendationJuly 11, 2025 | msn.comUntapped Patient Base, Ingrezza Growth Keep Neurocrine (NBIX) on Guggenheim’s Buy ListJuly 11, 2025 | finance.yahoo.comBank of New York Mellon Corp Has $91.65 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 11, 2025 | marketbeat.comGoldman Sachs Initiates Coverage On Neurocrine Biosciences (NBIX) With Buy Rating | NBIX Stock NewsJuly 10, 2025 | gurufocus.comThe Goldman Sachs Group Begins Coverage on Neurocrine Biosciences (NASDAQ:NBIX)July 10, 2025 | marketbeat.comBuy Rating for Neurocrine Biosciences Inc. Driven by Crenessity Launch and Discounted ValuationJuly 10, 2025 | tipranks.comA Glimpse Into The Expert Outlook On Neurocrine Biosciences Through 14 AnalystsJuly 9, 2025 | benzinga.comNeurocrine Biosciences Inc (NBIX) Announces Q2 2025 Financial Results Conference Call and ...July 9, 2025 | gurufocus.comNeurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2025 Financial ResultsJuly 9, 2025 | prnewswire.comUBS Group Issues Positive Forecast for Neurocrine Biosciences (NASDAQ:NBIX) Stock PriceJuly 9, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock Position Lessened by Brown Advisory Inc.July 9, 2025 | marketbeat.comPrincipal Financial Group Inc. Has $27.48 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 9, 2025 | marketbeat.com Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address NBIX Media Mentions By Week NBIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBIX News Sentiment▼0.460.64▲Average Medical News Sentiment NBIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBIX Articles This Week▼2317▲NBIX Articles Average Week Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Incyte News Today Exelixis News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Madrigal Pharmaceuticals News Today Halozyme Therapeutics News Today Ionis Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBIX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
